首页 › 食管癌 › 加利福尼亚州 › Los Angeles
Los Angeles CA 食管癌临床试验
15项针对 食管癌的研究正在 Los Angeles及周边约 30 英里内的站点招募参与者。打开研究详情可查看入选标准及联系研究团队的方式。
官方研究文本（英文）
正在为研究招募参与者？将此页面置顶展示 — $99 / 30天 →
A Study of LY4052031 in Participants With Advanced or Metastatic Urothelial Cancer or Other Solid Tumors
招募中1 期
- UCLA Department of Medicine-Hematology/Oncology, Los Angeles
A Study to Evaluate Investigational Agents With or Without Pembrolizumab (MK-3475) in Participants With Advanced Esophageal Cancer Previously Exposed to Programmed Cell Death 1 Protein (PD-1)/ Programmed Cell Death Ligand 1 (PD-L1) Treatment (MK-3475-06B)
招募中1/2 期
- UCLA Hematology/Oncology - Santa Monica ( Site 4905), Los Angeles
A Study to Learn About the Study Medicine Called PF-08046876 in People With Advanced Solid Tumors
招募中1 期
- Ronald Reagan UCLA Medical Center, Los Angeles
- UCLA Department of Medicine-Hematology/Oncology, Los Angeles
Safety and Efficacy of NEO212 in Patients With Astrocytoma IDH-mutant, Glioblastoma IDH-wildtype or Brain Metastasis
招募中1/2 期
- University of Southern California, Los Angeles
Using 18F-FAPI PET to Detect Metastatic Disease in Patients That Have Gastric or Esophageal Cancer.
招募中3 期
- UCLA, Los Angeles
Open Label Study to Evaluate BL-M07D1 in HER2 Expressing Malignant Solid Tumors
招募中1 期
- START - Los Angeles, Los Angeles
- Cedars Sinai, Los Angeles
Substudy 06D: Combination Therapies in Second Line (2L) Gastroesophageal Adenocarcinoma (MK-3475-06D/Keymaker-U06)
招募中1/2 期
- UCLA Hematology/Oncology - Santa Monica ( Site 8905), Los Angeles
Substudy 06C: A Study of Investigational Agents With Pembrolizumab (MK-3475) and Chemotherapy in Participants With First-Line Locally Advanced Unresectable/Metastatic Gastroesophageal Adenocarcinoma (MK-3475-06C/KEYMAKER-U06)
招募中1/2 期
- UCLA Hematology/Oncology - Santa Monica ( Site 6905), Los Angeles
A Study of Sigvotatug Vedotin in Advanced Solid Tumors
招募中1 期
- Ronald Reagan UCLA Medical Center, Los Angeles
- The Regents of the University of California, Los Angeles
- UCLA Department of Medicine-Hematology/Oncology, Los Angeles
Study to Assess Adverse Events and Pharmacokinetics in Adult Participants With Non-Small Cell Lung Cancer, Head and Neck Squamous Cell Carcinoma and Other Solid Tumors, Receiving Intravenous Infusion of Azirkitug Alone or in Combination(s) With Budigalimab, Bevacizumab, or Telisotuzumab Adizutecan
招募中1 期
- USC Norris Comprehensive Cancer Center /ID# 279603, Los Angeles
Comparative Effectiveness Trial of Two Supportive Cancer Care Delivery Models for Adults With Cancer
招募中
- Oncology Institute for Hope and Innovation, Los Angeles
Virtual Reality for GI Cancer Pain to Improve Patient Reported Outcomes
招募中
- Cedars-Sinai Medical Center, Los Angeles
A Study of MT-4561 in Patients With Various Advanced Solid Tumors
招募中1/2 期
- University of Southern California, Los Angeles
Intraoperative Imaging of Gastrointestinal Malignancies Using Pafolacianine (CYTALUX™)
招募中4 期
- Cedars-Sinai Medical Center, Los Angeles
TREAT-BE Study (Treatment With Resection and Endoscopic Ablation Techniques for Barrett's Esophagus)
招募中观察性研究欢迎健康志愿者
- UCLA Medical Center, Los Angeles
其他城市的 食管癌试验
- Houston, TX36 项研究
- Boston, MA23 项研究
- New York City, NY22 项研究
- Nashville, TN19 项研究
- St. Louis, MO17 项研究
- Pittsburgh, PA15 项研究
- Baldwin Park, CA14 项研究
- Grand Rapids, MI14 项研究
- Philadelphia, PA13 项研究
- San Antonio, TX12 项研究
- Arlington, VA11 项研究
- Rochester, MN11 项研究
Los Angeles的其他研究
- 非小细胞肺癌87 项研究
- 癌症（所有类型）74 项研究
- 乳腺癌73 项研究
- 前列腺癌61 项研究
- 结直肠癌59 项研究
- 转移性癌症57 项研究
- 卵巢癌50 项研究
- 肺癌45 项研究
- 头颈鳞状细胞癌42 项研究
- 胰腺癌35 项研究
- 子宫内膜癌34 项研究
- 黑色素瘤34 项研究
数据来自 ClinicalTrials.gov，检索日期：2026年10月6日。每项研究自行设定入选标准，由研究团队决定谁能参与。